RPL18 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.577200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.565600E-01
Normal-vs-Stage2
9.303600E-01
Normal-vs-Stage3
6.154200E-01
Normal-vs-Stage4
5.673200E-01
Stage1-vs-Stage2
6.787000E-01
Stage1-vs-Stage3
7.576400E-01
Stage1-vs-Stage4
2.852000E-01
Stage2-vs-Stage3
4.849600E-01
Stage2-vs-Stage4
1.504370E-01
Stage3-vs-Stage4
2.847000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.079000E-01
Normal-vs-AfricanAmerican
7.007400E-01
Normal-vs-Asian
6.349000E-01
Caucasian-vs-AfricanAmerican
1.114160E-01
Caucasian-vs-Asian
3.146800E-01
AfricanAmerican-vs-Asian
1.947030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.218400E-01
Normal-vs-Female
7.138200E-01
Male-vs-Female
1.253950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.229600E-01
Normal-vs-Age(41-60Yrs)
6.332800E-01
Normal-vs-Age(61-80Yrs)
9.513200E-01
Normal-vs-Age(81-100Yrs)
5.966000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.148200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.558000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.922560E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.116400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.066000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.947200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.582400E-01
Normal-vs-Daily Drinker
5.544600E-01
Normal-vs-Weekly Drinker
8.620000E-01
Normal-vs-Occasional Drinker
7.307600E-01
Normal-vs-Social Drinker
6.357600E-01
Non Drinker-vs-Daily Drinker
5.078300E-02
Non Drinker-vs-Weekly Drinker
5.218000E-01
Non Drinker-vs-Occasional Drinker
1.561040E-01
Non Drinker-vs-Social Drinker
2.879200E-01
Daily Drinker-vs-Weekly Drinker
7.114800E-01
Daily Drinker-vs-Occasional Drinker
4.819200E-01
Daily Drinker-vs-Social Drinker
7.279300E-03
Weekly Drinker-vs-Occasional Drinker
9.772400E-01
Weekly Drinker-vs-Social Drinker
2.975200E-01
Occasional Drinker-vs-Social Drinker
2.481700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.248200E-01
Normal-vs-Grade 2
5.852400E-01
Normal-vs-Grade 3
6.066400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.048200E-01
Grade 1-vs-Grade 3
3.499200E-01
Grade 1-vs-Grade 4
5.248200E-01
Grade 2-vs-Grade 3
7.910000E-01
Grade 2-vs-Grade 4
5.852400E-01
Grade 3-vs-Grade 4
6.066400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.669800E-01
Normal-vs-NonDiabetic
9.620200E-01
Diabetic-vs-NonDiabetic
9.852400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.040800E-01
Normal-vs-NoPancreatitis
9.801600E-01
Pancreatitis-vs-NoPancreatitis
7.580400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.193400E-01
Normal-vs-N1
8.551400E-01
N0-vs-N1
1.521390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.772000E-01
Normal-vs-TP53-NonMutant
9.254800E-01
TP53-Mutant-vs-TP53-NonMutant
2.220400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
